Literature DB >> 24138438

Covariate imbalance and adjustment for logistic regression analysis of clinical trial data.

Jody D Ciolino1, Renée H Martin, Wenle Zhao, Edward C Jauch, Michael D Hill, Yuko Y Palesch.   

Abstract

In logistic regression analysis for binary clinical trial data, adjusted treatment effect estimates are often not equivalent to unadjusted estimates in the presence of influential covariates. This article uses simulation to quantify the benefit of covariate adjustment in logistic regression. However, International Conference on Harmonization guidelines suggest that covariate adjustment be prespecified. Unplanned adjusted analyses should be considered secondary. Results suggest that if adjustment is not possible or unplanned in a logistic setting, balance in continuous covariates can alleviate some (but never all) of the shortcomings of unadjusted analyses. The case of log binomial regression is also explored.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24138438      PMCID: PMC4279871          DOI: 10.1080/10543406.2013.834912

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  23 in total

Review 1.  Analysis of randomized controlled trials.

Authors:  Peter Peduzzi; William Henderson; Pamela Hartigan; Philip Lavori
Journal:  Epidemiol Rev       Date:  2002       Impact factor: 6.222

Review 2.  The role of covariates in estimating treatment effects and risk in long-term clinical trials.

Authors:  Ian Ford; John Norrie
Journal:  Stat Med       Date:  2002-10-15       Impact factor: 2.373

3.  Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements.

Authors:  Adrián V Hernández; Ewout W Steyerberg; J Dik F Habbema
Journal:  J Clin Epidemiol       Date:  2004-05       Impact factor: 6.437

4.  Covariate imbalance and random allocation in clinical trials.

Authors:  S J Senn
Journal:  Stat Med       Date:  1989-04       Impact factor: 2.373

5.  Measuring continuous baseline covariate imbalances in clinical trial data.

Authors:  Jody D Ciolino; Reneé H Martin; Wenle Zhao; Michael D Hill; Edward C Jauch; Yuko Y Palesch
Journal:  Stat Methods Med Res       Date:  2011-08-24       Impact factor: 3.021

6.  Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics?

Authors:  E W Steyerberg; P M Bossuyt; K L Lee
Journal:  Am Heart J       Date:  2000-05       Impact factor: 4.749

7.  How to select covariates to include in the analysis of a clinical trial.

Authors:  G M Raab; S Day; J Sales
Journal:  Control Clin Trials       Date:  2000-08

8.  Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems.

Authors:  Stuart J Pocock; Susan E Assmann; Laura E Enos; Linda E Kasten
Journal:  Stat Med       Date:  2002-10-15       Impact factor: 2.373

9.  Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.

Authors:  Timothy John Ingall; William Michael O'Fallon; Kjell Asplund; Lewis Robert Goldfrank; Vicki S Hertzberg; Thomas Arthur Louis; Teresa J Hengy Christianson
Journal:  Stroke       Date:  2004-09-02       Impact factor: 7.914

10.  Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data.

Authors:  Glenn D Graham
Journal:  Stroke       Date:  2003-11-06       Impact factor: 7.914

View more
  12 in total

1.  Impact of baseline covariate imbalance on bias in treatment effect estimation in cluster randomized trials: Race as an example.

Authors:  Siyun Yang; Monique Anderson Starks; Adrian F Hernandez; Elizabeth L Turner; Robert M Califf; Christopher M O'Connor; Robert J Mentz; Kingshuk Roy Choudhury
Journal:  Contemp Clin Trials       Date:  2019-06-20       Impact factor: 2.226

2.  The impact of covariate adjustment at randomization and analysis for binary outcomes: understanding differences between superiority and noninferiority trials.

Authors:  Katherine Nicholas; Sharon D Yeatts; Wenle Zhao; Jody Ciolino; Keith Borg; Valerie Durkalski
Journal:  Stat Med       Date:  2015-02-02       Impact factor: 2.373

3.  Statistical properties of minimal sufficient balance and minimization as methods for controlling baseline covariate imbalance at the design stage of sequential clinical trials.

Authors:  Steven D Lauzon; Viswanathan Ramakrishnan; Paul J Nietert; Jody D Ciolino; Michael D Hill; Wenle Zhao
Journal:  Stat Med       Date:  2020-05-04       Impact factor: 2.373

4.  Continuous covariate imbalance and conditional power for clinical trial interim analyses.

Authors:  Jody D Ciolino; Renee' H Martin; Wenle Zhao; Edward C Jauch; Michael D Hill; Yuko Y Palesch
Journal:  Contemp Clin Trials       Date:  2014-03-07       Impact factor: 2.226

5.  Randomized Trial of an Intervention to Improve Blood Pressure Control in Stroke Survivors.

Authors:  Mayowa O Owolabi; Mulugeta Gebregziabher; Rufus O Akinyemi; Joshua O Akinyemi; Onoja Akpa; Olanrewaju Olaniyan; Babatunde L Salako; Oyedunni Arulogun; Raelle Tagge; Ezinne Uvere; Adekunle Fakunle; Bruce Ovbiagele
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-12-06

6.  Impact of minimal sufficient balance, minimization, and stratified permuted blocks on bias and power in the estimation of treatment effect in sequential clinical trials with a binary endpoint.

Authors:  Steven D Lauzon; Wenle Zhao; Paul J Nietert; Jody D Ciolino; Michael D Hill; Viswanathan Ramakrishnan
Journal:  Stat Methods Med Res       Date:  2021-11-29       Impact factor: 2.494

7.  Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study.

Authors:  Bolaji E Egbewale; Martyn Lewis; Julius Sim
Journal:  BMC Med Res Methodol       Date:  2014-04-09       Impact factor: 4.615

8.  Minimal sufficient balance randomization for sequential randomized controlled trial designs: results from the ESCAPE trial.

Authors:  Tolulope T Sajobi; Gurbakhshash Singh; Mark W Lowerison; Jordan Engbers; Bijoy K Menon; Andrew M Demchuk; Mayank Goyal; Michael D Hill
Journal:  Trials       Date:  2017-11-02       Impact factor: 2.279

9.  Prestroke Antiplatelet Effect on Symptomatic Intracranial Hemorrhage and Functional Outcome in Intravenous Thrombolysis.

Authors:  Jay Chol Choi; Ji Sung Lee; Tai Hwan Park; Yong-Jin Cho; Jong-Moo Park; Kyusik Kang; Kyung Bok Lee; Soo Joo Lee; Jae Guk Kim; Jun Lee; Man-Seok Park; Kang-Ho Choi; Joon-Tae Kim; Kyung-Ho Yu; Byung-Chul Lee; Mi-Sun Oh; Jae-Kwan Cha; Dae-Hyun Kim; Hyun-Wook Nah; Dong-Eog Kim; Wi-Sun Ryu; Beom Joon Kim; Hee-Joon Bae; Wook-Joo Kim; Dong-Ick Shin; Min-Ju Yeo; Sung Il Sohn; Jeong-Ho Hong; Juneyoung Lee; Keun-Sik Hong
Journal:  J Stroke       Date:  2016-09-30       Impact factor: 6.967

10.  Choosing an imbalance metric for covariate-constrained randomization in multiple-arm cluster-randomized trials.

Authors:  Jody D Ciolino; Alicia Diebold; Jessica K Jensen; Gerald W Rouleau; Kimberly K Koloms; Darius Tandon
Journal:  Trials       Date:  2019-05-28       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.